×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agendas
Codevelopment of a Drug in the Pharmaceutical Industry: Is It Ever Fun?
Session Chair(s)
Jayanthi Reddy, MBA, MS
Director, Global Project Management
Merck & Co., Inc., United States
A culture of collaboration with external partners is one of the key drivers of future success. This forum will focus on the challenges and barriers in codevelopment and the business models being adopted to ensure a healthy collaboration.
Learning Objective : Discuss a generic business model being adopted by pharmaceutical and biotechnology organizations for codevelopment of a drug; Describe the variations from the generic business model for successful codevelopment of a drug; Explain how the alliance manager and project manager can work together to make the collaboration fun and exciting.
Speaker(s)
Panelist
Douglas E Wilson, PharmD
GlaxoSmithKline, United States
Alliance Director
Panelist
Karla D'Alessio, PMP
Merck & Co., Inc., United States
Executive Director
Panelist
Elizabeth Somers, MS
Merck Sharp & Dohme LLC, United States
Executive Director, Global Project and Alliance Management
Have an account?
Ways to register
Registration override should work.